Trial Profile

Phase 1/2a, Proof-of-Concept, Multicenter, Parallel, Vehicle-Controlled, Double-Masked, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of IVW-1001 Ophthalmic Eyelid Wipe in Subjects With Dry Eye Disease

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 19 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

21 Oct 2025 According to an IVIEW Therapeutics media release, key findings from this trial were presented in two recent ReachMD podcast episodes, recorded in conjunction with the American Academy of Ophthalmology (AAO) 2025 Annual Meeting in Orlando, Florida.
01 Oct 2025 According to an IVIEW Therapeutics media release, abstract of this study accepted as an On-Demand Poster at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting.
10 Feb 2025 Topline results presented in the IVIEW Therapeutics Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com